Top analysts on stock perps · Analyst
Terence Flynn (Morgan Stanley): analyst track record on stock perps
Terence Flynn of Morgan Stanley on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.7★
Success61%
Excess return+10.9%
rank#733
Ratings397
ratings on stock perps569
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 265 | 760 |
| Stock | 48 | 49 |
| Buy / hold / sell | 128 / 122 / 15 | 347 / 368 / 45 |
| Upgrades / downgrades / initiations | 4 / 2 / 1 | 8 / 5 / 6 |
| Price targets hit / missed | 117 / 143 (45%) | 408 / 342 (54%) |
| Avg. return after a rating (TipRanks) | +16.0% | +13.3% |
| Best / worst call | +387.9% / -76.9% | +387.9% / -86.0% |
After buy calls: median 21-day move +1.3% · vs S&P 500 -0.5% · targets hit within a year 41% (n = 531)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $BNTX BioNTech SE | Buy · Maintained | $115 | +19.3% | Sep 8, 2026 |
| $VRTX Vertex Pharmaceuticals | Buy · Initiated | $665 | +29.2% | Sep 1, 2026 |
| $GILD Gilead Sciences, Inc. | Buy · Maintained | $165 | +13.9% | Aug 20, 2026 |
| $AMGN Amgen Inc. | Hold · Maintained | $362 | -5.4% | Aug 19, 2026 |
| $MRK Merck & Co., Inc. | Buy · Upgraded | $179 | +23.7% | Aug 19, 2026 |
| $MRNA Moderna, Inc. | Hold · Maintained | $89.00 | -34.9% | Aug 19, 2026 |
| $BMY Bristol Myers Squibb | Sell · Maintained | $40.00 | -37.3% | Aug 14, 2026 |
| $LLY Eli Lilly and Company | Buy · Reiterated | $1,419 | +26.4% | Aug 6, 2026 |
| $PFE Pfizer Inc. | Hold · Maintained | $28.00 | +1.3% | Aug 4, 2026 |
| $ABBV AbbVie Inc. | Buy · Reiterated | $296 | +16.1% | Aug 3, 2026 |
| $JNJ Johnson & Johnson | Buy · Maintained | $294 | +10.4% | Aug 3, 2026 |
| $REGN Regeneron Pharmaceuticals, Inc. | Hold · Maintained | $758 | -4.4% | Jul 31, 2026 |
| $BIIB Biogen Inc. | Hold · Maintained | $231 | +7.2% | Jul 30, 2026 |
Recent ratings
- Sep 8, 2026 $BNTX: Maintained · Buy · $115 · article
- Sep 1, 2026 $VRTX: Initiated · Buy · $665 · article
- Aug 31, 2026 $BNTX: Reiterated · Buy · $115 · article
- Aug 24, 2026 $BNTX: Reiterated · Buy · $115 · article
- Aug 20, 2026 $GILD: Maintained · Buy · $165 · article
- Aug 19, 2026 $MRNA: Maintained · Hold · $89.00 · article
- Aug 19, 2026 $MRK: Upgraded · Buy · $179 · article
- Aug 19, 2026 $AMGN: Maintained · Hold · $362 · article
- Aug 17, 2026 $BNTX: Reiterated · Buy · $115 · article
- Aug 14, 2026 $BMY: Maintained · Sell · $40.00 · article
- Aug 10, 2026 $BNTX: Reiterated · Buy · $115 · article
- Aug 6, 2026 $LLY: Reiterated · Buy · $1,419 · article
- Aug 5, 2026 $GILD: Maintained · Buy · $165 · article
- Aug 5, 2026 $AMGN: Reiterated · Hold · $351 · article
- Aug 4, 2026 $PFE: Maintained · Hold · $28.00 · article
- Aug 5, 2026 $MRK: Reiterated · Hold · $116 · article
- Aug 3, 2026 $JNJ: Maintained · Buy · $294 · article
- Aug 5, 2026 $BNTX: Reiterated · Buy · $115 · article
- Aug 3, 2026 $MRNA: Reiterated · Hold · $39.00 · article
- Aug 3, 2026 $ABBV: Reiterated · Buy · $296 · article
Terence Flynn4.7★ · 61% success · +10.9% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.